13/10/2025
๐๐ก๐ข๐ง๐ค๐ข๐ง๐ ๐จ๐ ๐ ๐๐ญ๐ญ๐ข๐ง๐ ๐ฉ๐ซ๐จ๐๐ข๐จ๐ญ๐ข๐๐ฌ ๐๐จ๐ซ ๐.๐๐ฒ๐ฅ๐จ๐ซ๐ข ๐๐๐๐ญ๐๐ซ๐ข๐๐ฅ ๐ข๐ง๐๐๐๐ญ๐ข๐จ๐ง ๐๐ฎ๐ญ ๐ง๐จ๐ญ ๐ฌ๐ฎ๐ซ๐ ๐ฐ๐ก๐ข๐๐ก ๐จ๐ง๐ ๐ฐ๐จ๐ซ๐ค๐ฌ?
Letโs talk about the important probiotic in this case: Lactobacillus reuteri DSM17648 โ a probiotic known for its targeted action against H. pylori. It is under trademark name Pylopassโข๏ธ, clinically studied with various papers.
๐๐ก๐จ ๐ฌ๐ก๐จ๐ฎ๐ฅ๐ ๐๐จ๐ง๐ฌ๐ข๐๐๐ซ ๐ญ๐๐ค๐ข๐ง๐ ๐ข๐ญ?
1๏ธโฃ Those currently on H. pylori triple or quadruple therapy
2๏ธโฃ Those tested H. pylori positive but can't or donโt want to take antibiotics.
3๏ธโฃ Those with higher risk of infection (e.g., frequent acid reflux, or close family members of infected individuals).
๐๐ก๐๐ญโ๐ฌ ๐ญ๐ก๐ ๐ซ๐ข๐ ๐ก๐ญ ๐๐จ๐ฌ๐?
โ
Based on clinical studies, the minimum effective daily dose is 200 mg. [1]
โ
Pyloress/Pylomax offer 100 mg per unit , just consume twice a day.
๐ฌ ๐๐ก๐ฒ ๐ข๐ฌ ๐ญ๐ก๐ ๐๐จ๐ฌ๐๐ ๐ ๐ข๐ง ๐ฆ๐ , ๐ง๐จ๐ญ ๐๐
๐?
Because Pylopassโข๏ธ uses inactivated bacteria, not live ones. Thatโs why mg is the correct unit โ CFU would be inaccurate here.
Consult us to seek more information regarding Pyloress and Pylomax!
Hpylori
[1] Mehling, H., & Busjahn, A. (2013). Non-viable Lactobacillus reuteri DSMZ 17648 (Pylopassโข) as a new approach to Helicobacter pylori control in humans. Nutrients, 5(8), 3062โ3073. https://doi.org/10.3390/nu5083062